Dissecting the treatment-naive ecosystem of human melanoma brain metastasis
Jana Biermann(Columbia University Irving Medical Center), Peter Canoll(Columbia University Irving Medical Center), Santiago J. Carmona(University of Geneva), Simon Berhe(Columbia University Irving Medical Center), Varun Sahu(Columbia University Irving Medical Center), Shivem B. Shah(Columbia University Irving Medical Center), Irving Barrera(Broad Institute), Markus D. Siegelin(Columbia University Irving Medical Center), Peter D. Koch(Columbia University), Alcida Karz(New York University), Joseph Driver(Brigham and Women's Hospital), Samuel F. Bakhoum(Memorial Sloan Kettering Cancer Center), Matthew Ingham(Columbia University), Margot Chazotte(Heidelberg University), Kristjan H. Gretarsson(Columbia University Irving Medical Center), Zachary Walsh(Columbia University Irving Medical Center), Adrienne Luoma(Harvard University), Nelson Humala(Texas Health Dallas), Patricia Ho(Columbia University Irving Medical Center), Suthee Rapisuwon(Georgetown University), Johannes C. Melms(Columbia University Irving Medical Center), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Florian Wünnemann(Heidelberg University), Michael B. Atkins(Georgetown University), Lindsay Caprio(Columbia University Irving Medical Center), Ajay Nair(Columbia University), Thomas Eigentler(University Children's Hospital Tübingen), Aayushi Mahajan(Texas Health Dallas), Benjamin T. Fullerton(Columbia University), Meri Rogava(Columbia University Irving Medical Center), Matei A. Banu(Stanford Medicine), Albert S. Agustinus(Memorial Sloan Kettering Cancer Center), Michael Mu(Columbia University Irving Medical Center), Blake Caldwell(Columbia University), Elham Azizi(Columbia University Irving Medical Center), Somnath Tagore(Columbia University Irving Medical Center), Vaibhav S. Mangipudy(Columbia University Irving Medical Center), Trang Nguyen(Columbia University), Antoni Ribas(University of California, Los Angeles), Hanina Hibshoosh, Chao Lü(Columbia University Irving Medical Center), Richard D. Carvajal(Northwell Health), Daniel H. Vaccaro(Columbia University), Miguel A. Ibarra-Arellano(Heidelberg University), Martin Röcken(German Cancer Research Center), Craig L. Slingluff(University of Virginia Health System), Yiping Wang(University of Electronic Science and Technology of China), Massimo Andreatta(University of Geneva), Shaheer Khan(Columbia University Irving Medical Center), Amit Dipak Amin(University of Cambridge)
Cited by 216
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Pembrolizumab versus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2015|5.8k
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
|Journal of Clinical Investigation|2017|3.9k